Skip to Main Content

Paper Details

A novel rapamycin cream formulation improves facial angiofibromas associated with tuberous sclerosis complex: a double-blind randomized placebo-controlled trial.
1
2023
FA, FAs, Facial Angiofibroma, Facial angiofibromas, Participants, Skin adverse reactions, TSC, facial angiofibromas, participant, participants, patients, rapamycin, tuberous sclerosis complex
Author NameAffiliation
Stacie StapletonJohns Hopkins All Children's Hospital
  • 1 - 1

Datasets

Release 1.2